Cargando…

Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV(smm/mac) Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization

As a consequence of their independent evolutionary origins in apes and Old World monkeys, human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency viruses of the SIV(smm/mac) lineage express phylogenetically and antigenically distinct envelope glycoproteins. Thus, HIV-1 Env-specific a...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Bredow, Benjamin, Andrabi, Raiees, Grunst, Michael, Grandea, Andres G., Le, Khoa, Song, Ge, Berndsen, Zachary T., Porter, Katelyn, Pallesen, Jesper, Ward, Andrew B., Burton, Dennis R., Evans, David T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606807/ https://www.ncbi.nlm.nih.gov/pubmed/31266872 http://dx.doi.org/10.1128/mBio.01255-19

Ejemplares similares

The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template
por: Andrabi, Raiees, et al.
Publicado: (2019)

Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein
por: Grunst, Michael W., et al.
Publicado: (2023)

A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies
por: Bibollet-Ruche, Frederic, et al.
Publicado: (2023)

Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
por: Voss, James E., et al.
Publicado: (2017)

Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
por: Voss, James E., et al.
Publicado: (2018)

Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design
por: Rantalainen, Kimmo, et al.
Publicado: (2018)

A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
por: Lee, Jeong Hyun, et al.
Publicado: (2017)

Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies
por: Pedreño-Lopez, Nuria, et al.
Publicado: (2020)

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV(mac251) acquisition in macaques
por: Rahman, Mohammad Arif, et al.
Publicado: (2023)

HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage
por: Landais, Elise, et al.
Publicado: (2017)

Cross clade reactive plasma anti-V3 antibodies in human immunodeficiency virus type-1 infected individuals develop with time
por: Andrabi, Raiees, et al.
Publicado: (2012)

Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation
por: Guzzo, Christina, et al.
Publicado: (2018)

Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
por: Yang, Yuhe R., et al.
Publicado: (2020)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021)

Characterization of human anti-V3 monoclonal antibody 904 isolated from an Indian clade C Human Immunodeficiency Virus type-1 (HIV-1) infected donor
por: Andrabi, Raiees, et al.
Publicado: (2013)

Probing Biology with Small Molecule Microarrays (SMM)
por: Winssinger, Nicolas, et al.
Publicado: (2007)

Lv4, an activity that restricts nuclear entry of SIV(MAC)/SIV(SM) in human blood cells
por: Pizzato, Massimo, et al.
Publicado: (2013)

P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
por: Basavapathruni, A, et al.
Publicado: (2009)

Transfer of knowledge in international cooperation: the Farmanguinhos – SMM case
por: da Silva, Samuel Araujo Gomes, et al.
Publicado: (2017)

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
por: Jia, Bin, et al.
Publicado: (2009)

Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys
por: Nguyen, Quang N., et al.
Publicado: (2018)

HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
por: Planes, Rémi, et al.
Publicado: (2023)

HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
por: Nogal, Bartek, et al.
Publicado: (2020)

Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from subtype-C HIV-1 infected north Indians; implications for MPER directed HIV-1 neutralization
por: Andrabi, Raiees, et al.
Publicado: (2012)

Psychometric properties of the Stress Mindset Measure (SMM) in the Polish population
por: Mierzejewska-Floreani, Dorota, et al.
Publicado: (2022)

Russian adaptation of Stress Mindset Measure-General (SMM-G)
por: Lebedeva, N., et al.
Publicado: (2022)

Neutralization of Tier-2 Viruses and Epitope Profiling of Plasma Antibodies from Human Immunodeficiency Virus Type 1 Infected Donors from India
por: Andrabi, Raiees, et al.
Publicado: (2012)

HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies
por: Rantalainen, Kimmo, et al.
Publicado: (2020)

Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer
por: Cao, Liwei, et al.
Publicado: (2018)

Using genomics to better define high-risk MGUS/SMM patients
por: Dutta, Ankit K., et al.
Publicado: (2018)

Patterns of HIV/SIV Prevention and Control by Passive Antibody Immunization
por: Yamamoto, Hiroyuki, et al.
Publicado: (2016)

Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
por: Martinez-Navio, José M., et al.
Publicado: (2020)

Impaired RNA incorporation and dimerization in live attenuated leader-variants of SIV(mac239)
por: Whitney, James B, et al.
Publicado: (2006)

ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIV(mac)251 Challenge
por: Alpert, Michael D., et al.
Publicado: (2012)

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIV(mac251) Rectal Challenge
por: Tuero, Iskra, et al.
Publicado: (2015)

Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques
por: Li, Hongzhao, et al.
Publicado: (2017)

Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors
por: Andrabi, Raiees, et al.
Publicado: (2012)

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
por: Presley, Chaela, et al.
Publicado: (2015)

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
por: Mateos, María-Victoria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v2le80naij736itts5g910rga9